Intravenous Gammaglobulin (IVIG) Plus Rituximab Improves Chances For Successful Kidney Transplantation In High Immunologic-risk Patients

 16.07.2008 21:10   medicalnewstoday.com

A new therapy developed at Cedars-Sinai Medical Center improves transplant rates and outcomes for patients awaiting living- and deceased-donor kidney transplantation, according to a study published in the July 17 issue of the New England Journal of Medicine.

World Transplantation